Home - News

News

Groupement de Recherche Cosm’actifs – GDR 3711

  • By maria
  • on Déc 04, 2017
Adjuvatis is invited to present the results of researches conducted on drug delivery in the skin by using the i-Particles.
Read More

Funding awarded for an Innovative Training Network, DRIVE!

  • By maria
  • on Déc 04, 2017
Adjuvatis is hiring a PhD Student for 3 years starting at May 2018 The European Innovative Training Network DRIVE (Driving.
Read More

11ème édition des Journées Collaboratives

  • By Charlotte PRIMARD
  • on Déc 04, 2017
Adjuvatis is going to the Partnering Days organized by the Bio Cluster Lyonbiopole to participate in brainstorming sessions and to.
Read More

Antibiotic incorporation in jet-sprayed nanofibrillar biodegradable scaffolds for wound healing

  • By Charlotte PRIMARD
  • on Déc 04, 2017
Abstract In view of preparing antibiotic-loaded structures that can be used as dressing to prevent or contain wound infections, this.
Read More

FASTCURE: a consortium of experts to respond to the epidemic COVID-19 coronavirus outbreak

  • By Charlotte PRIMARD
  • on Juin 11, 2020
FASTCURE is a consortium of experts for screening, identification and formulation of chemical compounds to combat SARS-CoV-2. Drug repurposing can.
Read More

A recombinant vaccine based on i-Particles is protective against H1N1 influenza infection

  • By Charlotte PRIMARD
  • on Juin 11, 2020
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection Context Cilian AG (Germany), affiliated as.
Read More

Solubilization of an hydrophobic API for anti-cancer treatment

  • By Charlotte PRIMARD
  • on Juin 18, 2020
Poor water solubility is one of the most significant barrier limiting drug development. Indeed, more than 40% of compounds identified.
Read More